BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22122518)

  • 1. Targeting the liver stage of malaria parasites: a yet unmet goal.
    Rodrigues T; Prudêncio M; Moreira R; Mota MM; Lopes F
    J Med Chem; 2012 Feb; 55(3):995-1012. PubMed ID: 22122518
    [No Abstract]   [Full Text] [Related]  

  • 2. Dormancy in mammalian malaria.
    Markus MB
    Trends Parasitol; 2012 Feb; 28(2):39-45. PubMed ID: 22118814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.
    Douglass AN; Kain HS; Abdullahi M; Arang N; Austin LS; Mikolajczak SA; Billman ZP; Hume JCC; Murphy SC; Kappe SHI; Kaushansky A
    Mol Ther; 2015 May; 23(5):857-865. PubMed ID: 25648263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.
    Kato N; March S; Bhatia SN; Marti M
    Methods Mol Biol; 2018; 1787():41-52. PubMed ID: 29736708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroquinazolinone inhibitors of proliferation of blood and liver stage malaria parasites.
    Derbyshire ER; Min J; Guiguemde WA; Clark JA; Connelly MC; Magalhães AD; Guy RK; Clardy J
    Antimicrob Agents Chemother; 2014; 58(3):1516-22. PubMed ID: 24366746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of metal-based antimalarial agents: implications for the mechanism of action.
    Biot C; Castro W; Botté CY; Navarro M
    Dalton Trans; 2012 Jun; 41(21):6335-49. PubMed ID: 22362072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of malaria parasites. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1987; 743():1-229. PubMed ID: 3109131
    [No Abstract]   [Full Text] [Related]  

  • 8. Stopping malaria parasites dead in their tracks.
    Doerig CD
    Nat Chem Biol; 2008 Jun; 4(6):334-5. PubMed ID: 18488008
    [No Abstract]   [Full Text] [Related]  

  • 9. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma.
    Baum J; Gilberger TW; Frischknecht F; Meissner M
    Trends Parasitol; 2008 Dec; 24(12):557-63. PubMed ID: 18835222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomic analysis of Plasmodium, the causal agent of Malaria].
    Castro R I; Rodríguez G Mdel C
    Salud Publica Mex; 2009; 51 Suppl 3():S395-402. PubMed ID: 20464213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Plasmodium Plasmepsin V: Hitting Two Birds with One Stone.
    Brancucci NMB; Heussler VT; Grüring C
    Trends Parasitol; 2020 Feb; 36(2):85-87. PubMed ID: 31883707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New malaria drugs: screening against the entire parasite or target-based - which is the right path?].
    Schlitzer M
    Pharm Unserer Zeit; 2011 May; 40(3):190-1. PubMed ID: 21698606
    [No Abstract]   [Full Text] [Related]  

  • 13. Redefining the role of de novo fatty acid synthesis in Plasmodium parasites.
    Tarun AS; Vaughan AM; Kappe SH
    Trends Parasitol; 2009 Dec; 25(12):545-50. PubMed ID: 19819758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sneaking in through the back entrance: the biology of malaria liver stages.
    Frevert U
    Trends Parasitol; 2004 Sep; 20(9):417-24. PubMed ID: 15324732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of efficacy to accelerate drug discovery in malaria.
    Jiménez-Díaz MB; Viera S; Fernández-Alvaro E; Angulo-Barturen I
    Parasitology; 2014 Jan; 141(1):93-103. PubMed ID: 23789594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
    Wells TN; Burrows JN; Baird JK
    Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites.
    Manzoni G; Briquet S; Risco-Castillo V; Gaultier C; Topçu S; Ivănescu ML; Franetich JF; Hoareau-Coudert B; Mazier D; Silvie O
    Sci Rep; 2014 Apr; 4():4760. PubMed ID: 24755823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug discovery: where next?
    Burrows JN
    Future Med Chem; 2012 Dec; 4(18):2233-5. PubMed ID: 23234546
    [No Abstract]   [Full Text] [Related]  

  • 19. Do the mitochondria of malaria parasites behave like the phoenix after return in the mosquito? Regeneration of degenerated mitochondria is required for successful Plasmodium infection.
    Bongaerts G
    Med Hypotheses; 2005; 64(3):599-601. PubMed ID: 15617875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium ovale: observations on the parasite development in Saimiri monkey hepatocytes in vivo and in vitro in contrast with its inability to induce parasitemia.
    Millet P; Nelson C; Galland GG; Sullivan JS; Morris CL; Richardson BB; Collins WE
    Exp Parasitol; 1994 Jun; 78(4):394-9. PubMed ID: 8206138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.